-
公开(公告)号:US20170197968A1
公开(公告)日:2017-07-13
申请号:US15326262
申请日:2015-07-14
申请人: Arthur LEE , John C. MCKEW , Paresma R. PATEL , Paul B. YU , Agustin H. MOHEADS , Philip E. SANDERSON , Wei ZHENG , Xiuli HUANG , THE BRIGHAM AND WOMEN'S HOSPITLAL, INC. , THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN , UNIVERSITY OF HOUSTON SYSTEM
发明人: Arthur Lee , John C. McKew , Paresma R. Patel , Paul B. Yu , Agustin H. Mohedas , Philip E. Sanderson , Gregory D. Cuny , Wei Zheng , Xiuli Huang
IPC分类号: C07D487/04 , C07D519/00
CPC分类号: C07D487/04 , C07D519/00
摘要: The present invention provides small-molecule inhibitors of BMP signaling and compositions and methods for inhibiting BMP signaling. These compounds and compositions may be used to modulate cell growth, differentiation, proliferation, and apoptosis, and thus may be useful for treating diseases or conditions associated with BMP signaling, including inflammation, cardiovascular disease, hematological disease, cancer, and bone disorders, as well as for modulating cellular differentiation and/or proliferation. These compounds and compositions may also be used to reduce circulating levels of ApoB-100 or LDL and treat or prevent acquired or congenital hypercholesterolemia or hyperlipoproteinemia; diseases, disorders, or syndromes associated with defects in lipid absorption or metabolism; or diseases, disorders, or syndromes caused by hyperlipidemia.
-
公开(公告)号:US10513521B2
公开(公告)日:2019-12-24
申请号:US15326262
申请日:2015-07-14
申请人: The Brigham and Women's Hospital, Inc. , The United States of America, as Represented by the Secretary, Department of Health and Human Services, National Institutes of Health , University of Houston System
发明人: Arthur Lee , John C. McKew , Paresma R. Patel , Paul B. Yu , Agustin H. Mohedas , Philip E. Sanderson , Gregory D. Cuny , Wei Zheng , Xiuli Huang
IPC分类号: C07D487/04 , C07D519/00
摘要: The present invention provides bicyclic heteroaryl inhibitors of BMP signaling and compositions and methods for inhibiting BMP signaling. Exemplary compounds include those of Formula I: These compounds and compositions may be used to modulate cell growth, differentiation, proliferation, and apoptosis, and thus may be useful for treating diseases or conditions associated with BMP signaling, including inflammation, cardiovascular disease, hematological disease, cancer, and bone disorders, as well as for modulating cellular differentiation and/or proliferation. These compounds and compositions may also be used to reduce circulating levels of ApoB-100 or LDL and treat or prevent acquired or congenital hypercholesterolemia or hyperlipoproteinemia; diseases, disorders, or syndromes associated with defects in lipid absorption or metabolism; or diseases, disorders, or syndromes caused by hyperlipidemia.
-
公开(公告)号:US20170305883A1
公开(公告)日:2017-10-26
申请号:US15516273
申请日:2015-10-01
申请人: THE BRIGHAM AND WOMEN'S HOSPITAL, INC. , THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SE.. , UNIVERSITY OF HOUSTON SYSTEM
发明人: Paul B. Yu , Gregory D. Cuny , Agustin H. Mohedas , Arthur Lee
IPC分类号: C07D401/14 , C07D409/04 , C07D403/02 , C07D401/04 , C07D221/22 , C07D213/02 , A61K31/551 , C07D417/14 , A61K31/44
CPC分类号: C07D401/14 , A61K31/44 , A61K31/551 , A61P3/00 , A61P5/00 , A61P9/00 , A61P29/00 , A61P31/00 , A61P35/00 , C07D213/02 , C07D213/38 , C07D213/61 , C07D213/64 , C07D213/73 , C07D213/74 , C07D221/22 , C07D401/04 , C07D403/02 , C07D405/04 , C07D409/04 , C07D417/14 , C07D487/04
摘要: The present invention provides small molecule inhibitors of BMP signaling and compositions and methods for inhibiting BMP signaling. These compounds and compositions may be used to modulate cell growth, differentiation, proliferation, and apoptosis, and thus may be useful for treating diseases or conditions associated with BMP signaling, including inflammation, cardiovascular disease, hematological disease, cancer, and bone disorders, as well as for modulating cellular differentiation and/or proliferation. These compounds and compositions may also be used to reduce circulating levels of ApoB-100 or LDL and treat or prevent acquired or congenital hypercholesterolemia or hyperlipoproteinemia; diseases, disorders, or syndromes associated with defects in lipid absorption or metabolism; or diseases, disorders, or syndromes caused by hyperlipidemia.
-
公开(公告)号:US11654147B2
公开(公告)日:2023-05-23
申请号:US17340589
申请日:2021-06-07
申请人: The Brigham and Women's Hospital, Inc. , The United States of America, as Represented by the Secretary, Department of Health and Human Services
发明人: Paul B. Yu , Wenwei Huang , Philip Edward Sanderson , Jian-Kang Jiang , Khalida Shamim , Wei Zheng , Xiuli Huang , Gregory Tawa , Arthur Lee , Asaf Alimardanov , Junfeng Huang
IPC分类号: A61K31/519 , A61P19/08 , A61K31/5377 , A61K31/551 , A61K31/675 , A61K45/06 , C07D487/04 , C07D519/00 , C07F9/6561
CPC分类号: A61K31/519 , A61K31/5377 , A61K31/551 , A61K31/675 , A61K45/06 , A61P19/08 , C07D487/04 , C07D519/00 , C07F9/6561
摘要: The present invention provides small-molecule inhibitors of BMP signaling and compositions and methods for inhibiting BMP signaling. These compounds and compositions may be used to modulate cell growth, differentiation, proliferation, and apoptosis, and thus may be useful for treating diseases or conditions associated with BMP signaling, including inflammation, cardiovascular disease, hematological disease, cancer, and bone disorders, as well as for modulating cellular differentiation and/or proliferation. These compounds and compositions may also be used to treat subjects with Sjögren's syndrome, or diffuse intrinsic pontine glioma (DIPG).
-
公开(公告)号:US10017516B2
公开(公告)日:2018-07-10
申请号:US15598540
申请日:2017-05-18
申请人: The Brigham and Women's Hospital, Inc. , The United States of America, as represented by the Secretary, Department of Health and Human Services, National Institute of Health
发明人: Asaf Alimardanov , Gregory D. Cuny , Gurmit S. Grewal , Arthur Lee , John C. McKew , Agustin H. Mohedas , Min Shen , Xin Xu , Paul B. Yu
IPC分类号: C07D487/04 , C07D519/00
CPC分类号: C07D487/04 , C07D519/00
摘要: The present invention provides small molecule inhibitors of BMP signaling. These compounds may be used to modulate cell growth, differentiation, proliferation, and apoptosis, and thus may be useful for treating diseases or conditions associated with BMP signaling, including inflammation, cardiovascular disease, hematological disease, cancer, and bone disorders, as well as for modulating cellular differentiation and/or proliferation. These compounds may also be used to reduce circulating levels of ApoB-100 or LDL and treat or prevent acquired or congenital hypercholesterolemia or hyperlipoproteinemia; diseases, disorders, or syndromes associated with defects in lipid absorption or metabolism; or diseases, disorders, or syndromes caused by hyperlipidemia.
-
公开(公告)号:US20230000869A1
公开(公告)日:2023-01-05
申请号:US17340589
申请日:2021-06-07
申请人: The Brigham and Women's Hospital, Inc. , The United States of America, as Represented by the Secretary, Department of Health and Human Servic
发明人: Paul B. Yu , Wenwei Huang , Philip Edward Sanderson , Jian-Kang Jiang , Khalida Shamim , Wei Zheng , Xiuli Huang , Gregory Tawa , Arthur Lee , Asaf Alimardanov , Junfeng Huang
IPC分类号: A61K31/519 , A61P19/08 , A61K31/5377 , A61K31/551 , A61K31/675 , A61K45/06 , C07D487/04 , C07D519/00 , C07F9/6561
摘要: The present invention provides small-molecule inhibitors of BMP signaling and compositions and methods for inhibiting BMP signaling. These compounds and compositions may be used to modulate cell growth, differentiation, proliferation, and apoptosis, and thus may be useful for treating diseases or conditions associated with BMP signaling, including inflammation, cardiovascular disease, hematological disease, cancer, and bone disorders, as well as for modulating cellular differentiation and/or proliferation. These compounds and compositions may also be used to treat subjects with Sjögren's syndrome, or diffuse intrinsic pontine glioma (DIPG).
-
公开(公告)号:US11026947B2
公开(公告)日:2021-06-08
申请号:US16608489
申请日:2018-04-26
申请人: The Brigham and Women's Hospital, Inc. , The United States of America, As Represented By The Secretary, Department Of Health And Human Services
发明人: Paul B. Yu , Wenwei Huang , Philip Edward Sanderson , Jian-Kang Jiang , Khalida Shamim , Wei Zheng , Xiuli Huang , Gregory Tawa , Arthur Lee , Asaf Alimardanov , Junfeng Huang
IPC分类号: A61K31/519 , A61K31/5377 , A61K31/551 , A61P19/08 , A61K31/675 , A61K45/06 , C07D487/04 , C07D519/00 , C07F9/6561
摘要: The present invention provides small-molecule inhibitors of BMP signaling and compositions and methods for inhibiting BMP signaling. These compounds and compositions may be used to modulate cell growth, differentiation, proliferation, and apoptosis, and thus may be useful for treating diseases or conditions associated with BMP signaling, including inflammation, cardiovascular disease, hematological disease, cancer, and bone disorders, as well as for modulating cellular differentiation and/or proliferation. These compounds and compositions may also be used to treat subjects with Sjögren's syndrome, or diffuse intrinsic pontine glioma (DIPG).
-
8.
公开(公告)号:US20160000794A1
公开(公告)日:2016-01-07
申请号:US14858929
申请日:2015-09-18
申请人: The United States of America, as represented by the Secretary, Department of Health and Human Serv , University of Florida Research Foundation, Incorporated , The General Hospital Corporation , Brigham and Women's Hospital Inc.
发明人: John A. Chiorini , Hongen Yin , Cuong Nguyen , Donald B. Bloch , Paul B. Yu
IPC分类号: A61K31/519
CPC分类号: A61K31/519
摘要: The finding that patients with Sjögren's syndrome exhibit a statistically significant increase in expression of BMP6 in the salivary gland, relative to healthy control subjects, is described. Also described is the finding that overexpression of BMP6 in the salivary glands of mice results in an increase in electrical potential across the salivary gland. Methods of diagnosing a subject as having Sjögren's syndrome, or at risk for developing Sjögren's syndrome, by measuring the level of BMP6 expression in a salivary gland of a subject, measuring electrical potential in a salivary gland of a subject, or both, are described. Methods of treating a subject with Sjögren's syndrome, or methods of increasing salivary flow in a subject, by administering an agent that inhibits BMP6 expression or activity are also described. The use of XIST and MECP2 as diagnostic and therapeutic targets for male Sjögren's syndrome patients is further described.
摘要翻译: 描述了相对于健康对照受试者,Sjögren综合征患者在唾液腺中BMP6表达统计学显着增加的发现。 还描述了BMP6在小鼠唾液腺中的过表达导致跨越唾液腺的电位增加的发现。 描述了通过测量受试者唾液腺中BMP6表达的水平,测量受试者的唾液腺中的电势或两者来诊断受试者患有Sjögren综合征或具有发展Sjögren综合征风险的方法。 还描述了通过施用抑制BMP6表达或活性的药物治疗患有Sjögren综合征的受试者的方法或增加受试者中唾液流的方法。 进一步描述使用XIST和MECP2作为男性Sjögren综合征患者的诊断和治疗靶标。
-
公开(公告)号:US08507501B2
公开(公告)日:2013-08-13
申请号:US12922122
申请日:2009-03-13
IPC分类号: A01N43/90 , A61K31/519 , C07D487/00
CPC分类号: C07D487/04 , A61K31/519
摘要: The present invention provides small molecule inhibitors of BMP signaling. These compounds may be used to modulate cell growth, differentiation, proliferation, and apoptosis, and thus may be useful for treating diseases or conditions associated with BMP signaling, including inflammation, cardiovascular disease, hematological disease, cancer, and bone disorders, as well as for modulating cellular differentiation and/or proliferation.
摘要翻译: 本发明提供BMP信号传导的小分子抑制剂。 这些化合物可用于调节细胞生长,分化,增殖和凋亡,因此可用于治疗与BMP信号相关的疾病或病症,包括炎症,心血管疾病,血液病,癌症和骨骼疾病,以及 用于调节细胞分化和/或增殖。
-
公开(公告)号:US20140038953A1
公开(公告)日:2014-02-06
申请号:US13979943
申请日:2012-01-20
IPC分类号: C07D487/04 , C07D471/04
CPC分类号: A61K31/519 , A61K31/4709 , A61K31/496 , A61K31/5377 , C07D471/04 , C07D487/04
摘要: The present invention provides small molecule inhibitors of BMP signaling. These compounds may be used to reduce circulating levels of ApoB-100 or LDL. These compounds may also be used to treat or prevent acquired or congenital hypercholesterolemia or hyperlipoproteinemia; diseases, disorders, or syndromes associated with defects in lipid absorption or metabolism; or diseases, disorders, or syndromes caused by hyperlipidemia.
摘要翻译: 本发明提供BMP信号传导的小分子抑制剂。 这些化合物可用于降低ApoB-100或LDL的循环水平。 这些化合物也可用于治疗或预防获得性或先天性高胆固醇血症或高脂蛋白血症; 与脂质吸收或代谢缺陷相关的疾病,病症或综合征; 或由高脂血症引起的疾病,病症或综合征。
-
-
-
-
-
-
-
-
-